Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
On the one hand, insurers recognize the potential for GLP-1 drugs to reduce costly chronic conditions, but on the other, are wary of the sheer scale and cost of widespread adoption
Kalra, S., Sahay, R., & Gupta, Y
In some cases, drug interactions may lead to reduced effectiveness of spironolactone or increased side effects of other drugs
Nutritional interventions to counteract the detrimental consequences of early-life stress
The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain
doi:10.1007/s11882-014-0430-z Hodson T, Custovic A, Simpson A, Chapman M, Woodcock A, Green R
US$ 24.91
US$ 25.95
US$ 26.43
